Robinhood Stock Surges 1,000% Over 3 Years: Is the Rally at Risk?
November 27, 2025, 3:58 AM EST. Robinhood stock has defied the market, up more than 1,000% over the past three years, driven by a booming trading backdrop and expanding product suite. The platform is attracting new customers, boosting deposits, and monetizing via Gold membership and crypto trading. In the 2025 Q3 snapshot, revenue jumped to $1.3 billion and net income rose to $556 million, with 26.8 million customers and platform assets up double digits. Growth drivers include new products, higher trading activity, and the appeal of crypto and gold. Long-term, Robinhood is broadening into credit cards, savings, and even prediction markets, but there are risks and holes in the thesis as the market dynamics and crypto exposure remain volatile. Is the pullback a buying opportunity or the start of a top?
Smart Dividend Stocks to Buy Now: PepsiCo and Enterprise Products Partners Lead the Pack
November 27, 2025, 3:56 AM EST. With market valuations stretched, the article argues for shifting toward value stocks and, in particular, dividend stocks that provide income while you wait for the next market shift. It spotlights PepsiCo (PEP) as a better bet than Coca-Cola today, thanks to its diversified product mix (including Frito-Lay and Quaker Oats) and a 3.9% yield underpinned by a 53-year dividend growth streak. Despite inflation headwinds, the mix offers potential for recovery in snacks and beverages over time. The other pick, Enterprise Products Partners (EPD), is a less glamorous but essential player, operating a large pipeline and storage network that underpins energy infrastructure and pays dependable income. Together, these names illustrate a practical way to start with income-focused exposure.
Is EMCOR Group Really Undervalued After a 19% Pullback?
November 27, 2025, 3:54 AM EST. EMCOR Group has rallied 33.5% YTD but pulled back 19.1% in the last month, fueling questions about fair value. A DCF-based analysis points to intrinsic value well above the current price: using a 2-Stage DCF to Equity model on a $1.15B Free Cash Flow base and analyst projections, the estimate sits near $909.27 per share, implying a 32.8% discount to market. The model leans on steady cash-flow growth and strong contract wins in government services, alongside broader U.S. infrastructure trends. While valuation looks compelling, investors should balance this against forward earnings and execution risk. In short, the stock appears undervalued on the cash-flow model, but a cautious, diversified approach remains prudent.
AST SpaceMobile Valuation Under Scrutiny After 156% YTD Surge and Pullback
November 27, 2025, 3:52 AM EST. AST SpaceMobile (ASTS) has drawn attention after a 156.56% YTD gain, followed by a 30.12% pullback over the last month. The three-year total shareholder return stands at 862.22%, reflecting strong investor belief in its space-based broadband vision, but execution risks remain. The stock trades at a lofty P/B of 12.4x, far above the US Telecom average (1.2x) and peer average (6.3x), suggesting investors are pricing in substantial growth despite ongoing losses. A DCF model places fair value at $196.12 per share, implying a 71.7% discount to the current price ($55.52). If growth materials, upside exists; otherwise, risk of mispricing remains. Key risks: profitability, scaling the satellite network, and capital intensity. SWS DCF methodology further explains the valuation.
Nifty50, Sensex at fresh lifetime highs: Drivers, risks, and 2026 outlook
November 27, 2025, 3:48 AM EST. Indian benchmarks Nifty50 and Sensex surged to new lifetime highs as FIIs returned to Dalal Street and global banks raised targets for 2026. Domestic institutions added to the buying momentum. Analysts credit a mix of factors: improving earnings growth in FY25, valuations turning reasonable, and a brighter earnings outlook from firms across sectors. Optimism on an India-US trade deal, low inflation, and a potential RBI rate cut bolster the case for sustaining gains. Banks like Morgan Stanley, JPMorgan, and Goldman Sachs have lifted forecasts, with JPMorgan penciling Nifty50 at around 30,000 by end-2026 and Morgan Stanley signaling a Sensex near 1,00,000. The market remains vulnerable to policy shifts and external risks, but the sense is that a broader rally could persist if earnings keep recovering and risk sentiment stays constructive.
Jefferies Reiterates Underperform on Rightmove plc Depositary Receipt (RTMVY); ~25.7% Upside to $17.78
November 27, 2025, 3:40 AM EST. Jefferies reiterates an Underperform rating on Rightmove plc – Depositary Receipt (RTMVY). The one-year price target is $17.78, about 25.7% upside from the latest close of $14.15. Targets range from $12.84 to $24.36. Projected revenue is $386M (down 5.79%), with non-GAAP EPS of $0.28. Fund sentiment shows 11 funds/institutions hold RTMVY, averaging a 0.73% portfolio weight, up 0.56%. Total institution ownership rose to 958K shares. Notable holders include JNL Series Trust (648K) and SkyView Investment Advisors (63K). The note comes from Fintel, highlighting ownership shifts and upside versus the current price.
JP Morgan Cazenove Reiterates Underweight on Rightmove plc – Depositary Receipt (RTMVY); One-Year Target ~$17.78
November 27, 2025, 3:38 AM EST. JP Morgan Cazenove reiterated an Underweight rating on Rightmove plc – Depositary Receipt (RTMVY). The firm's one-year price target is about $17.78, up from a close of $14.15, implying ~25.66% upside. Target range spans $12.84-$24.36. Projected 2025 revenue is $386M (down 5.79%) with a non-GAAP EPS of $0.28. Fund sentiment shows 11 funds/institutions hold RTMVY, averaging 0.73% of portfolios, up 0.56%. Total shares owned by institutions: 958K (up 0.07%). Notable holders include JNL Series Trust (648K) and CFSLX (183K); SkyView Investment Advisors (63K, +1.4%), Wesbanco Bank (30K); VCKSX (20K, -5.38%). Source: Fintel; reflects positioning and targets rather than Nasdaq/issuer views.
U.S. stock market closed for Thanksgiving as NYSE/Nasdaq observe holiday; shortened Friday session ahead
November 27, 2025, 3:34 AM EST. The US stock market is closed on Thanksgiving Day (Thu, Nov 27, 2025) per the NYSE holiday list, with NYSE and Nasdaq observing a full market holiday and no trading in ETFs or options. Bond markets are also closed. Ahead of the break, the market had logged a four-session rally led by tech stocks, with the Dow Jones Industrial Average up 314.67 points, the S&P 500 up 46.73, and the Nasdaq Composite up 189.10 on Wednesday. Trading will resume on Friday, Nov 28, 2025, in a shortened session for Black Friday. Expect focus on the Fed's possible December rate cut as investors reassess risk and seasonality.
JP Morgan Cazenove Reiterates Neutral on Bodycote (BYPLF) as Institutional Ownership Rises
November 27, 2025, 3:32 AM EST. JP Morgan Cazenove reiterated a Neutral stance on Bodycote (BYPLF) as of November 25, 2025. The buy-side spotlight shows 72 institutions owning BYPLF, a rise of 2 entities in the last quarter, with the average portfolio weight at 0.13% (up 6.59%). Institutional ownership climbed 6.81% to 28.847 million shares. Key holders include: Fidelity Series International Small Cap Fund (FSTSX) with 5.505m shares (3.12%), up 29.09% allocation; Fidelity International Small Cap Opportunities Fund (FSCOX) with 2.684m (1.52%), up 16.30%; DFA International Small Cap Value Portfolio – Institutional Class (DISVX) with 2.576m (1.46%), up 8.10%; Vanguard Total International Stock Index Fund (VGTSX) with 2.562m (1.45%), up 21.47%; Fidelity International Small Cap Fund (FISMX) with 2.311m (1.31%), up 27.83%.
Moore Threads IPO Draws 4,126x Subscriptions as Chinese Nvidia Rival Eyes AI GPU Race
November 27, 2025, 3:29 AM EST. Moore Threads, a Beijing-based GPU maker founded in 2020 by former Nvidia engineers, is raising $1.1 billion in an IPO to fund R&D for next-generation GPUs. The plan aims to capitalize on a growing Chinese AI and gaming market and to challenge Nvidia as U.S. export controls tighten in China. Early demand appears fierce, with reports of 4,126x subscriptions, underscoring appetite for a domestic GPU alternative. Proceeds will prioritize innovation over near-term profitability. Analysts note the IPO unfolds amid policy headwinds against foreign chipmakers and a race to close the gap in performance and cost. Market chatter also ties Meta and Google potential deals over TPUs to recent volatility.
Sensex rises 300 pts, Nifty hits record high as FII buying fuels rally
November 27, 2025, 3:18 AM EST. Equity benchmarks extended gains as the Sensex crossed 86,000 and the Nifty topped a record 26,300, backed by sustained FII buying and expectations of Fed rate cuts. At 10:15 AM, the Sensex added about 318 points to ~85,928 and the Nifty stood near 26,278, with leaders including Bajaj Finance, Shriram Finance, Asian Paints, Bajaj Finserv and L&T among the top gainers. Net foreign inflows totalled ₹4,778 crore, sparking fresh risk appetite. Analysts say upcoming quarterly earnings growth in FY26 and a domestic consumption pickup support the rally, though lofty valuations temper expectations for a sharp sustained move. Global cues point to a likely Fed rate cut in December and softer crude aiding inflation containment.
Nukkleus SPAC SC II IPO Priced at $10, to Raise $150M on Nasdaq
November 27, 2025, 3:08 AM EST. Nukkleus-led SC II Acquisition Corp priced its units at $10.00, aiming to raise $150 million in gross proceeds, with an underwriter option for up to $22.5 million. Each unit includes one Class A ordinary share and a right to receive 1/5 of a share upon a future business combination. The securities will trade on Nasdaq Global Market under the ticker SCIIU, with closing expected around November 28, 2025. The Sponsor will purchase 255,000 sponsor units at $10 each. Management, led by Menachem Shalom, signals acquisition flexibility and balance-sheet optionality in the aerospace and defense sector. Potential dilution and float impacts arise from the 1/5 share rights and the underwriter option, while the IPO provides near-term cash to pursue a target.
Strategy (MSTR) Stock Dips as Bitcoin Slump Sparks Index-Outflow Fears
November 27, 2025, 3:04 AM EST. Strategy shares fell 3.9% after Bitcoin slid and reports warned MSCI may exclude digital-asset holders from its indices. Bitcoin traded near $80,500, squeezing Strategy's holdings into marginal profitability and raising the specter of fund outflows, a scenario JPMorgan estimated could reach $2.8B-$8.8B. The stock closed at $170.25, its lowest in a year, underscoring volatility and a market that prices in macro risks. With MSCI index considerations and rate expectations shaping flows, Strategy remains down about 42.9% YTD and well below its 52-week high. The piece also notes a broader rotation from high-growth names to defensives as Nvidia's rally fades in a higher-for-longer environment.
Prashant Jain: IPO themes could disappoint; large-caps favored, cautious on small-/mid-caps and consumption
November 27, 2025, 3:02 AM EST. Prashant Jain argues Indian large-caps can compound around 11-12% over 3-5 years, as overall valuations look reasonable today (around 20x forward) with pockets of expensive stock, and dispersion across names remains low. He prefers large-caps to small-/mid-caps and warns against overpaying for theme-driven bets. On IPOs and popular themes such as consumption, he notes many names are expensive relative to growth; even as organised retail and home-improvement seek fast growth, multiples leave little room for comfort. He sees capex and core infra in a different cycle from 2003-2008-no meaningful shortages and faster growth not likely to mirror that era. Overall, he remains cautious about manufacturing, capital goods, and defence as overvalued, and doubts small-/mid-caps will sustain high returns.
Berenberg Reiterates Hold on GSK ADR as Target Sees Modest Upside
November 27, 2025, 3:00 AM EST. Berenberg Bank reiterates a Hold rating on GSK plc – Depositary Receipt (NYSE:GSK). The latest target implies a one-year price target of about $47.60, with a range of $32.05-$69.98. The target represents a 0.10% upside from the recent close of $47.55. Fintel notes broad fund sentiment: 1,058 funds hold positions, averaging 0.40% of portfolios (up 2.47%), with institutions owning about 489.563M shares (up 0.53%). The put/call ratio sits at 0.48, signaling bullish tilt. Leading holders include Dodge & Cox (≈78.4M shares) and Fisher Asset Management (≈32.2M), with Primecap, Vanguard funds also sizable. The model projects revenue of $31,763MM (−1.25%) and non-GAAP EPS of 1.64.
Newegg (NEGG) Valuation Under Scrutiny After Aggressive Rally
November 27, 2025, 2:56 AM EST. Newegg Commerce (NEGG) has attracted renewed investor attention as momentum builds in e-commerce and electronics retail. The stock has surged 29.6% over the past week and a staggering 758% year-to-date, with a 542%1-year total shareholder return. Despite the rally, valuation remains contested: the stock trades at a price-to-sales (P/S) ratio of 1.2x, above the US Specialty Retail industry average of 0.5x, signaling a premium for growth or optimism about the business. The latest price was $76.49, versus a peer average P/S of 1.1x. Fundamental risk factors include persistent net losses and unclear revenue growth. A DCF-based fair value sits at just $4.16 per share, suggesting potential overvaluation if cash-flow expectations prove too optimistic. Investors should weigh growth expectations against fundamentals.
Abbott to Acquire Exact Sciences for $21 Billion as EXAS Rallies
November 27, 2025, 2:54 AM EST. Exact Sciences (EXAS) surged after Abbott Laboratories (ABT) announced a roughly $21 billion deal to acquire the cancer screening specialist, paying $105 per share. The transaction, expected to close in Q2 next year, values Exact at a premium and highlights demand for cancer-screening and precision oncology. Exact Sciences' tests such as Cologuard contributed about $3.2 billion in projected 2025 revenue; the company reported Q3 revenue of $851 million. Abbott says the U.S. cancer screening and precision oncology market is around $60 billion. Traders sent EXAS up about 17% on the news, while ABT dipped. Analysts noted the deal's financing could affect its attractiveness, despite the compelling strategic rationale. The broader cancer-screening market remains a growth driver for healthcare investors.
Nasdaq P/E Insights: Is NDAQ Overvalued Relative to Capital Markets Peers?
November 27, 2025, 2:50 AM EST. Nasdaq Inc. (NDAQ) is trading at $89.13, down 0.01% in the session, with a 1-month gain of 5.63% and a 12-month gain of 8.72%. The focal point for investors is whether the stock is overvalued based on the P/E ratio. Nasdaq's P/E of 31.84 sits above the Capital Markets industry average of 24.4, implying the market may be pricing in stronger future growth or a premium for scale. However, a higher P/E doesn't guarantee outperformance and can reflect optimistic expectations. The takeaway: the P/E is useful but should be evaluated alongside growth prospects, margins, qualitative factors, and industry trends before deciding on NDAQ.
3 UK Penny Stocks With Market Caps Below £4B: Notable Picks and Health Ratings
November 27, 2025, 2:48 AM EST. The UK equities backdrop has pressured the market, with the FTSE 100 and FTSE 250 slipping on weaker Chinese trade data. Against this backdrop, penny stocks-small, growth-minded names-remain in focus for value and upside. A screen of UK stocks with market caps under £4B highlights names like DSW Capital (AIM: DSW) at £12.31M, Foresight Group Holdings (LSE: FSG), Warpaint London (AIM: W7L), Quartix Technologies (AIM: QTX), and Ingenta (AIM: ING). Other listed peers include System1 Group (AIM: SYS1) and Integrated Diagnostics Holdings (LSE: IDHC). The table shows Financial Health Ratings ranging from five-star to upper-mid ratings, signaling resilience despite volatility. Investors should perform due diligence and consider how these catalysts fit their risk tolerance.
Moore Threads IPO on STAR Market: China's First Homegrown GPU Debuts at 114.28 yuan
November 27, 2025, 2:45 AM EST. Moore Threads, China's first homegrown GPU maker, kicked off its STAR Market IPO, pricing at 114.28 yuan per share and aiming to raise about 8 billion yuan with costs around 424 million yuan. The listing positions the firm to a post-issuance market cap near 54 billion yuan, and its founder Zhang Jianzhong holds about 36.36% stake, worth close to 6 billion yuan after the offering. Despite rapid revenue growth, the company remains loss-making due to heavy R&D investment, with profitability expected by 2027. The IPO underscores China's push for technological self-reliance in the domestic GPU sector, though Moore Threads and peers face technology gaps, talent shortages, and high R&D costs. The deal marks a milestone in building an independent semiconductor ecosystem.
Digital Asset Treasuries Under Pressure as Crypto Slump Triggers Billions in Unrealized Losses
November 27, 2025, 2:42 AM EST. Digital asset treasuries led by BitMine, Metaplanet and SharpLink carry about $5.8 billion in unrealized losses as a broader crypto rout drags prices lower. The downturn has pushed these DATs' stock values below their crypto holdings, compressing mNAV ratios (BitMine ~0.73x, SharpLink ~0.82x, Forward Industries ~0.74x). While some firms still have cash to operate, analysts warn ongoing price declines imperil market access for new equity and raise liquidity pressure. A near-$1 billion liquidations spike as Bitcoin traded near $82,000 underscores how forced selling could become a steady source of downward pressure on the market. The situation tests the sustainability of the "digital asset treasury" playbook.
European Markets Seen Higher On Thursday as Fed Rate-Cut Bets Support Risk Appetite
November 27, 2025, 2:40 AM EST. European stocks are poised to open higher on Thursday, following firmer Wall Street and renewed Fed rate-cut expectations that are lifting risk appetite. Wednesday's session saw gains after a tech-led rally in the US, with the Stoxx 50 up and DAX advances helping Europe finish on a positive note. France's CAC 40 and the UK's FTSE 100 posted solid results as investors priced in further monetary easing and a potential peace deal in Ukraine. Futures point to continued upside for European indices, with DAX and Stoxx 50 contracts modestly higher. In Asia, markets also climbed on stimulus hopes. The USD softened, with the EUR/USD near 1.160, while gold and crude oil slipped on easing bets.
Miami International Holdings Announces Sale of MIAXdx to Robinhood Markets in Partnership with Susquehanna International Group
November 27, 2025, 2:38 AM EST. Miami International Holdings announced it will sell 90% of MIAXdx to Robinhood Markets, in partnership with Susquehanna International Group, while retaining a 10% stake. MIAXdx is a CFTC-approved Designated Contract Market (DCM) and Derivatives Clearing Organization (DCO) that lists and clears fully collateralized futures, options on futures and swaps. The deal, expected to close in Q1 2026 and subject to customary closing conditions and CFTC filings, aims to accelerate exposure to prediction markets via the retained equity. CEO Thomas P. Gallagher described the move as a strategic collaboration with industry leaders to expand innovative trading products. Robinhood's JB Mackenzie framed it as a step toward serving customers, with MIAX continuing growth across its exchanges.
Santa Claus rally lifts Nifty50 past 26,200; Sensex surges over 1,000 points on upbeat global cues
November 27, 2025, 2:34 AM EST. India's benchmarks snapped a three-day dip as the Nifty50 closed at 26,205.30 (+320.50) and the Sensex jumped to 85,609.51 (+1,022.50). In early trade, gains persisted on a buoyant global backdrop amid a festive Santa Claus rally. A slide in crude oil near $60/bbl supported macro sentiment by trimming the oil import bill and cutting input costs for energy-intensive sectors like paints, chemicals, logistics and aviation. JP Morgan even floated a potential Brent drop toward $30 by FY27, a medium-term tailwind for India. Global peers were broadly higher, with US futures up and Asian markets in the green. Domestic inflows aided the rally: FIIs bought Rs 785.32 crore and DIIs added Rs 3,912.47 crore. Rate-cut hopes from the Fed and RBI further lifted sentiment.
Robinhood expands prediction markets with futures exchange; HOOD stock climbs
November 27, 2025, 2:32 AM EST. Robinhood is expanding into prediction markets by launching a futures and derivatives exchange, run via a joint venture with Susquehanna International Group. The move comes as HOOD stock has surged, up about 10% midweek and more than tripled this year, underscoring its status among the S&P 500's top gainers. The exchange will help Robinhood become a one-stop shop for trading stocks, crypto, and events contracts, and includes a 90% stake acquisition of MIAXdx, a CFTC-licensed derivatives clearing house, with MIAX retaining the rest. The deal is slated to close in Q1 next year. Robinhood will continue to partner with multiple DCM/DCO partners. CEO Vlad Tenev says prediction-market activity is booming, with volume doubling each quarter since launch to 2.3 billion contracts in Q3.
General Dynamics (NYSE: GD): Steady EPS Growth and Revenue Momentum Signal Durable Value
November 27, 2025, 2:30 AM EST. General Dynamics (NYSE: GD) is presented as a profitable, well-established defender-contractor with growing earnings. Over the last three years, its EPS has grown about 8.9% annually, suggesting durable profitability. Revenue rose about 12% to around US$52b, supported by stable EBIT margins, which kept profitability on an upward track rather than a margin squeeze. The combination of rising earnings and solid top-line growth supports a view that the company can fund continued value creation for shareholders. Insider ownership adds a management-level alignment, with insiders holding roughly 0.7% of the company and a stake valued at about US$607m. While past performance isn't a guarantee of future returns, the stock's earnings trajectory and cash-generating potential position GD as a viable candidate for longer-term investors seeking quality franchises.
US Stock Market Today: S&P 500, Nasdaq Jump Ahead of Thanksgiving
November 27, 2025, 2:26 AM EST. US stocks edged higher on Wednesday ahead of the Thanksgiving holiday, with the major indexes on track for their fourth straight session of gains. The Dow rose 171 points (0.4%) at the open, while the S&P 500 climbed 0.5% and the Nasdaq Composite added 0.7%. Nvidia jumped more than 2% after its pullback, and Microsoft gained about 1%. Nine of the 11 sector indices on the S&P traded higher, led by information technology and utilities, with telecom and healthcare lower. Analysts are turning bullish for 2026: Deutsche Bank targets the S&P 500 at 8,000 by year-end 2026 (roughly an 18% rally), while JPMorgan Chase sees 7,500 and Societe Generale about 7,300, per Bloomberg.
Salesforce Stock Falls as Market Rises Ahead of Dec 3 Earnings
November 27, 2025, 2:24 AM EST. Salesforce.com (CRM) closed at $228.15, down 2.55% on the session, underperforming the S&P 500's 0.69% gain as the Dow and Nasdaq rose. Over the past month, CRM has fallen about 7.92%, lagging the Computer and Technology sector. Investors will watch its upcoming earnings report on December 3, 2025, with consensus calls for EPS of $2.85, up about 18.3% year over year, and quarterly revenue around $10.26 billion, up roughly 8.7%. For the full year, estimates point to EPS of $11.36 and revenue of $41.21 billion, up mid-single digits. The stock trades at a Forward P/E of 20.62 with a PEG of 1.39, slightly below the industry. Zacks assigns CRM a Rank #3 (Hold), reflecting mixed near-term momentum.
Bitcoin Rebounds Above $90,000 as Risk Rally Broadens
November 27, 2025, 2:22 AM EST. Bitcoin climbed above $90,000 for the first time in almost a week, recouping losses after a month-long selloff as a broad rally in risk assets and easing volatility boosted upside. The move mirrors gains in equities amid growing conviction that the Fed may resume rate cuts. BlackRock's US Bitcoin ETF attracted fresh inflows, snapping a streak of redemptions as demand returns. Liquidity remains thin ahead of the Thanksgiving break, but with volatility ebbing and little evidence of fresh forced selling, bulls appear to be testing whether the worst of the drawdown has passed.
Black Friday 2025 Trading Hours: U.S. Stock Market Opens 9:30 AM, Early Close at 1:00 PM ET
November 27, 2025, 2:20 AM EST. On Friday, November 28, 2025 (Black Friday), U.S. stocks trade 9:30 a.m.-1:00 p.m. ET, with an early close to cap the Thanksgiving week. The NYSE and Nasdaq designate this as an early-close day; many options may close around 1:15 p.m. ET. Bond markets shorten to about 2:00 p.m. ET per SIFMA guidance. This is part of the Thanksgiving week pattern: a normal Wednesday, a closed Thursday, and a shortened Friday. Investors should place and exit orders by the early afternoon to avoid liquidity gaps before the holiday weekend.
Matsuya Co., Ltd. (TSE:8237) Stock Surges 58% in 3 Months Despite Low ROE – What Investors Should Watch
November 27, 2025, 2:18 AM EST. Stock: Matsuya Co., Ltd. (TSE:8237) has jumped about 58% over three months. The latest ROE sits at about 1.7% (TTM to Aug 2025), well below the industry average of ~9.7%, signaling weak profitability on equity. Despite this, Matsuya delivered roughly 41% net income growth over the past five years, well above the industry growth of 14%. This divergence suggests other drivers, such as high earnings retention or efficient management. The company shows a low three-year payout ratio of 20%, implying ~80% of earnings are retained for reinvestment. Investors should assess whether the recent price move is justified given the ROE and should compare valuation metrics with peers.
Bitcoin Rebounds Ahead of Thanksgiving as Short Liquidations Unwind and ETF Flows Boost Rally
November 27, 2025, 2:16 AM EST. Bitcoin jumped about 4% ahead of Thanksgiving, attracting bullish chatter as traders weigh the recent price action. The rally appears supported by a discounting of short liquidations (shorts outpaced longs by about 5-to-1 in the last 24 hours) and a rise in capital flows into spot Bitcoin ETFs and other direct BTC funds. Analysts note Bitcoin's higher beta correlation with the Nasdaq and growth stocks can magnify upside (and downside). While the near-term direction remains uncertain, a further unwind of bearish bets alongside sustained ETF demand could drive faster gains than many equities. Still, the path ahead is unclear, and investors should watch liquidity, derivatives activity, and market correlation as Thanksgiving trading unfolds.
Evercore ISI reiterates Aura Biosciences Outperform with 238% upside (AURA)
November 27, 2025, 2:14 AM EST. Evercore ISI Group reiterated an Outperform rating on Aura Biosciences (AURA) as of Nov. 26, 2025. The target implies about 238% upside versus Aura's latest close, with a range of $17.17-$23.10 and an average target of $20.66. The forecast highlights revenue of around $6M and a non-GAAP EPS of -2.25 for the year. Fund ownership remains broad: 236 institutions hold Aura shares, with an average weight of 0.25% and total shares of 55.031M. The put/call ratio sits at 0.01, signaling a bullish tilt. Notable holders include Matrix Capital Management, Frazier Life Sciences, Adage Capital, Long Focus, and Suvretta Capital, each with multi-million share stakes.
Is Rubrik Undervalued After 37% Surge Fueled by Cloud Partnerships
November 27, 2025, 1:59 AM EST. Rubrik has climbed about 37% over the past year, even as a 2.7% dip last week and a 12.4% drop in the last month add volatility. Cloud partnerships and data-security momentum have boosted sentiment, but the stock still rates 3/6 on our undervaluation checks. Our Discounted Cash Flow (DCF) model puts an intrinsic value of about $83.14 per share, roughly 18% above the current price, suggesting Rubrik is undervalued relative to its long-term cash-flow potential. The analysis uses a two-stage FCF-to-equity framework with a projected Free Cash Flow of $765.9M by 2030. While near-term forecasts carry risk, the framework highlights a potential entry point for patient investors as growth remains robust and partnerships deepen.
SAP Share Price Dip: AI Partnerships Could Signal Opportunity Amid Undervalued Valuation
November 27, 2025, 1:56 AM EST. SAP shares have cooled after a multi-year rally, down ~12% in the last month and ~13% YTD as investors weigh growth. Headline talk of AI integrations and expanded global partnerships supports sentiment despite the pullback. A DCF view from Simply Wall St shows SAP as undervalued, with intrinsic value around €253.82 per share – about 18.6% above current levels. Forecasts project Free Cash Flow rising from €6.4B to €9.6B by 2027, with longer-term upside beyond €16.9B by 2035. The analysis notes a mid-range valuation score (3/6) and hints at a deeper dive into the method and smarter checks later. For investors, the setup suggests potential opportunity if AI-driven moats translate into durable competitive advantages.
BofA Securities Maintains Nutanix Buy Rating; PT Up ~49% to $87.65
November 27, 2025, 1:48 AM EST. BofA Securities maintained a Buy rating on Nutanix (NTNX) on November 26, 2025. The analyst price target sits at $87.65 – about 49.1% upside from the recent close of $58.77. The targets range from $71.71 to $99.75. The projection calls for $2,683M in annual revenue and a non-GAAP EPS of $1.31, down about 21.6% from prior forecasts. Fund sentiment shows 1,186 institutions holding NTNX, with average exposure near 0.25% of portfolios and total NTNX shares held rising ~4.7% to 273.4M. The put/call ratio is 0.38, pointing to a bullish tilt. Major owners include FDGRX, Vanguard funds, AQR Capital, Generation Investment Management, and NAESX, all adjusting NTNX positions last quarter.
HC Wainwright Initiates Coverage on reAlpha Tech (AIRE) with Buy; 68.8% Upside Forecast
November 27, 2025, 1:46 AM EST. HC Wainwright & Co. initiates coverage on reAlpha Tech (AIRE) with a Buy rating. The target implies about a 68.81% upside from the latest close of $0.53 to a $0.89 median one-year target, with a range of $0.50-$1.31. The projected annual non-GAAP EPS is -0.15. Fund sentiment shows 31 institutions, up 3.12% this quarter; total shares owned rose 127.57% to 3.60 million. Notable holders include Geode Capital (427K, 0.33%), Vanguard's VTSMX (290K), Virtu Financial (114K), Scientech Research (113K), and Northern Trust (109K). The update highlights broad data on fundamentals, ownership, and sentiment available on Fintel.
Peel Hunt Reiterates Buy on Diversified Energy (DEC), Signals ~86% Upside
November 27, 2025, 1:44 AM EST. Peel Hunt Limited reaffirmed its Buy stance on Diversified Energy (DEC) on November 25, 2025. The broker's latest price forecast signals ~86.74% upside from the November 17, 2025 target of $27.81, with a wide range of $14.96-$42.40 and a close around $14.89. The forecast accompanies expected annual revenue of $1,065 million and non-GAAP EPS of $0.14. On the fund side, 188 institutions hold DEC, down about 34% in the quarter, with average weights near 0.11% and total shares around 37.4 million (−3.3% QoQ). Major holders include Ameriprise (4.109M), COAVX (2.644M), Citadel Advisors (2.379M), Tejara (1.953M), and M&G (1.915M). The note also points to Fintel's research resources.
Nifty50 hits lifetime high near 26,300; Sensex tops 86,000 on bullish setup
November 27, 2025, 1:42 AM EST. Stocks built on a bullish tone as Indian benchmarks extended gains, with Nifty50 briefly crossing 26,300 and BSE Sensex around 85,900. At 10:19 AM, Nifty stood at 26,278 (+0.28%), while the Sensex traded near 85,900 (+0.34%). Analysts point to improving Q3 demand, capex prospects, and expectations of rate cuts from the RBI and the US Federal Reserve as catalysts for further upside. In global markets, US equities rose on rate-cut hopes, while Asian peers followed higher. Gold steadied after a prior peak. FPIs remained net buyers, supported by domestic institutions. Cautious near-term patience advised, as valuation and festival-season moderation could cap gains, but a further rally remains possible if earnings momentum sustains.
Jefferies Maintains Buy on Nektar Therapeutics (NKTR) with ~58.6% Upside to $95.73 Target
November 27, 2025, 1:33 AM EST. Jefferies reiterates a Buy rating on Nektar Therapeutics (NKTR). As of Nov. 17, 2025, the firm's average one-year price target stands at $95.73, implying ~58.6% upside from NKTR's close of $60.35 on Nov. 26, 2025. Targets range from $30.30 to $126.00. The company's projected annual revenue is $100M (↑~59.9%), while estimated non-GAAP EPS is -1.19. On fund sentiment, 218 funds/institutions own NKTR, up ~78.7% quarter over quarter; average weight 0.23%; total shares held ~15.19M (↑97.3%). The put/call ratio sits at 0.25, signaling bullishness. Top holders include BVF (1.28M, 6.28%), Susquehanna (0.93M), Farallon (0.79M), Millennium (0.55M), and Two Sigma (0.43M). Source: Fintel.
Citigroup Initiates Coverage on Nektar Therapeutics (NKTR) with Buy; ~58.6% Upside to $95.73
November 27, 2025, 1:30 AM EST. Citigroup has initiated coverage of NKTR with a Buy rating. The target price implies about a 58.63% upside to the latest close, with an average one-year target of $95.73 (range $30.30-$126.00). That compares with a $60.35 close, implying a ~58.63% lift. Fintel notes projected annual revenue of $100MM and non-GAAP EPS of -1.19. Fund sentiment remains constructive: 218 funds own NKTR, up 78.69% this quarter, with average weight 0.23% and total shares at 15,187K. The put/call ratio is 0.25. Major holders include Bvf, Susquehanna, Farallon, Millennium, and Two Sigma.
Barrington Research Maintains PowerFleet (AIOT) Outperform; 131% Upside Implied
November 27, 2025, 1:28 AM EST. Barrington Research has maintained an Outperform rating on PowerFleet (AIOT), signaling continued conviction for the IoT fleet-management company. The firm's latest forecast points to an average one-year target of $10.88, implying about 131.49% upside from the late-November price of $4.70. The target range spans $8.08-$15.75. Upcoming metrics include projected annual non-GAAP EPS of 0.34. Asset-manager sentiment remains constructive: 347 funds hold AIOT, with a collective 0.25% portfolio weight and roughly 133,053K shares owned. The put/call ratio sits at 0.04, underscoring a bullish tilt. Notable holders include Private Capital Management, Disciplined Growth Investors, Voss Capital, Private Management Group, and AWM Investment, each with multi-million share stakes.
Goldman Sachs Maintains Buy on Broadcom (AVGO) with Modest Upside
November 27, 2025, 1:16 AM EST. Goldman Sachs reaffirmed a Buy rating on Broadcom (AVGO) on November 26, 2025. The firm's target implies about a 3.06% upside to the November 17 target of $396.82 per share, from a current close around $385.03. The one-year target range spans $220.18-$504.00. Investors should note the sentiment signals: the put/call ratio sits at 1.04, pointing to a bearish tilt, though funds remain broadly positioned. Institutional holders total 4,284,169K shares across 6,286 funds, with an average portfolio weight of 1.63% for AVGO, up roughly 11.17% quarter over quarter. Notable owners include Vanguard, Capital International, Capital World Investors, and Geode Capital. Fintel provides comprehensive data on ownership, sentiment, and more.
HC Wainwright Reiterates BiomX Buy; 173% Upside to $15.81 Target (PHGE)
November 27, 2025, 1:14 AM EST. HC Wainwright & Co. reiterates a Buy rating on BiomX (PHGE). The analyst price forecast points to a 173.53% upside with a target of $15.81 versus a $5.78 close. The one-year target range sits at $15.15-$16.80. The article notes a fund sentiment shift: 22 institutions hold PHGE, with an average portfolio weight of 0.01% and total PHGE shares of about 8.311 million (down 23.32% in three months). Major holders include Deerfield Management (2,494K; 163.37% ownership) and Nantahala (2,493K; 163.32%). Other owners: Alyeska (1,591K; 104.20%) and JPMorgan Chase (430K; 28.17%). The model shows 0MM revenue and -0.81 non-GAAP EPS for BiomX.
Tianyu Semiconductor launches $215M IPO as China market briefs highlight IPOs, fundraises and earnings shifts
November 27, 2025, 1:13 AM EST. China market briefs show active fundraising and shifting earnings across names. Tianyu Semiconductor launches a $215 million IPO, joining a slate that includes Xiao Noodles' Hong Kong IPO up to $89 million. Results are mixed: Baozun narrows operating profit as its e-commerce unit returns to profitability, while Noah Holdings posts a 63% profit jump despite weaker revenue. In financing rounds, Minieye seeks up to $26 million via a 10% discounted placement, and Ubtech targets about $400 million in a placement at an 11.4% discount. On the demand side, Cathay Pacific traffic rises; Luckin Coffee eyes global expansion, potentially pursuing Costa Coffee. So-Young, CSPC, and Yum China signal shifts to new formats, price pressures, and a bold 2030 expansion plan.
RadNet (RDNT): Valuation Near Fair Value as Momentum Builds
November 27, 2025, 1:09 AM EST. RadNet (RDNT) shares have quietly built momentum, with a 15.3% gain over 90 days and an 18% YTD rise, while a 318.8% three-year TSR underscores a long-run reward for early investors. The stock trades near a fair value of $86.67 vs a recent close around $82.79, suggesting a modest undervaluation as markets price in next-gen growth. Analysts factor in big future revenue and margin leaps, supported by aggressive expansion and a major digital health push with AI-powered imaging (DeepHealth, See-Mode, iCAD) boosting throughput and high-margin procedures. Risks include possible reimbursement headwinds that could cap margin gains and slow growth. The P/S ratio at 3.2x vs peers around 1.1x raises questions about upside; deeper numbers await in the narrative.
JPMorgan Upgrades ATMU to Overweight; $54.26 PT Signals ~13% Upside
November 27, 2025, 12:56 AM EST. JPMorgan has upgraded Atmus Filtration Technologies (ATMU) from Neutral to Overweight, signaling a more bullish view. The firm's price target sits at $54.26, implying ~12.98% upside from the latest close of $48.03, with a target range of $45.45 to $61.95. Projected annual revenue is $1,769MM and non-GAAP EPS is $2.31. The data point to strong institutional interest: about 638 funds own ATMU, with total shares held rising to ~102.1M and a put/call ratio of 0.05. Notable holders include Eminence Capital (8.00%), Price T. Rowe Associates (5.01%), Goldman Sachs (3.73%), Vanguard (3.28%), and Geode Capital (2.91%). The upgrade could lift attention on ATMU ahead of earnings and product news.
Nasdaq ISE Seeks to Quadruple IBIT Options Limits on BlackRock Bitcoin ETF
November 27, 2025, 12:22 AM EST. Nasdaq's International Securities Exchange (ISE) has filed with the SEC to raise IBIT options position limits from 250,000 to 1,000,000 contracts and to remove caps on customized FLEX options that are physically delivered. The plan would place IBIT on par with major equities and ETFs, boosting market depth and liquidity for institutional traders and market makers. Analysts say the higher limits could support larger, lower-risk allocation strategies and potentially compress volatility over the next year. The proposal highlights IBIT's $86.2 billion market cap and about 44.6 million shares of average daily volume. Public comments run through December 17, 2025, and SEC approval remains required before any changes take effect.
MINISO (NYSE:MNSO) Valuation Under Review After Strong Sales Growth and Upbeat Guidance
November 27, 2025, 12:08 AM EST. MINISO Group Holding (NYSE:MNSO) delivered strong sales growth in Q3 while net income declined, and issued positive earnings guidance. The stock has been volatile, with a sharp pullback in the past month, even as long-term total shareholder return remains solid (about 9% over one year, ~79% over three years). The setup points to a market weighing rapid top-line expansion against near-term profit pressures. Analysts note the stock trades ~40% below its average target of around $26.69, suggesting potential undervalued status if expansion remains on track. A key catalyst is store expansion, especially overseas, with MINISO targeting 900-1,100 net new stores in 2024 and a sizable international footprint. Risks include missteps in rapid rollout and underperforming super stores.
Kodiak Gas Services: NYSE Texas Dual Listing Sparks Valuation Review
November 27, 2025, 12:07 AM EST. Kodiak Gas Services (KGS) kicked off trading on NYSE Texas after announcing a dual listing, alongside a 10 million share offering and a plan to repurchase 1 million shares. The stock has drifted lower in 2024 (YTD -16.38%) but posted a 1-week gain of 3.47%, signaling fresh interest. The 1-year total shareholder return is -7.81%, underscoring a mixed setup where recent momentum could reflect shifting sentiment amid the new market access and capital actions. Analysts see upside with a fair value around $44.20 versus a close near $34.93, yet the stock trades at a P/E near 40x, well above energy services peers. Risks include labor shortages in the Permian, regulatory pressures, and execution risks of the rollout.
